Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1446 + Donepezil in Mild to Moderate Alzheimer's Disease
NCT01039701Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of azd1446 in Alzheimer's disease (AD), sponsored by AstraZeneca. Started Dec 2009; status: completed.
02
Drugs
azd1446
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01039701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039701.